Below are our latest posts regarding the coronavirus pandemic.
Filtered on: IP Insights Remove Filter
IP Insights
As the novel coronavirus (Covid-19) continues to ravage the United States, ensuring that frontline healthcare workers are adequately protected is of utmost importance. Among various types of proper protective equipment (PPE), none has become more synonymous with safety and protection than the N95 Respirator. Given the superior effectiveness of the N95 respirator over other prophylactic measures, demand is understandably high. Basic principles of economics suggest that increased demand for respirators will similarly increase the price paid by consumers. However, the dire need for PPE is motivating companies to forego increased profits to ensure that frontline personnel are adequately protected.
Read More
IP Insights
06.29.20
Prior USPTO CARES Act extensions waived certain fees and deadlines up until July 1, 2020. With the July 1, 2020 date looming and the need for relief remaining at a high level, today (June 29, 2020) the USPTO further extended the time for small and micro entities to pay certain patent-related fees that would otherwise have been due on or after March 27, 2020.
Read More
IP Insights
06.16.20
Yesterday, June 15, 2020, the USPTO announced a new COVID-19 prioritized examination program for certain trademark and service mark applications.
Read More
IP Insights
Time spent on securing Food and Drug Administration (FDA) approval for regulated products (such as pharmaceuticals, medical devices, and agrochemicals) effectively shortens the term of patent protection for the underlying invention of those products.
Read More
IP Insights
05.28.20
On May 27, 2020 the United States Patent and Trademark Office (USPTO) extended patent deadlines for small and micro entities to July 1, 2020.
Read More
IP Insights
05.08.20
Continuing its efforts to accelerate the commercialization and available of technologies addressing COVID-19, the United States Patent Office (USPTO) has announced a new COVID-19 Prioritized Examination Pilot Program.
Read More
IP Insights
05.05.20
Yesterday, May 4, 2020, the United States Patent and Trademark Office (USPTO) took a surprising leap into commercialization of patented and patent pending technologies, unveiling a web-based marketplace platform for intellectual property (IP).
Read More
IP Insights
04.29.20
Yesterday, April 28, 2020, pursuant to the temporary authority provided by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the United States Patent and Trademark Office (USPTO) announced further extensions to the time allowed for filing certain patent and trademark-related documents and to pay certain required fees. This new Notice supersedes the prior Notice published on March 31, 2020.
Read More
IP Insights
04.06.20
The United States Patent and Trademark Office today, April 6, 2020, published answers to common questions related to it’s recent Notice advising of the availability of 30 day extensions of time for certain actions impacted by COVID-19.
Read More
IP Insights
03.31.20
Today, March 31, 2020, pursuant to the temporary authority provided by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the United States Patent and Trademark Office (USPTO) announced extensions to the time allowed for filing certain patent and trademark-related documents and to pay certain required fees.
Read More
